MPFS Final Rule Decreases Conversion Factor for 2027
CMS finalized the 2027 Medicare Physician Fee Schedule, including conversion factor reductions and QPP policy updates.
Read moreThe Washington State Health Care Authority Health Technology Clinical Committee (HTCC) reviewed balloon angioplasty and stenting for lower extremity peripheral artery disease evidence Nov. 21. ACR® participated in the discussion along with the Society of Interventional Radiology, Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, and the Outpatient Endovascular and Interventional Society. ACR began monitoring this topic in August 2025.
HTCC issued draft findings and a coverage decision that are open for public comment until Dec. 16. The coverage determination is for Endovascular therapy for activity-limiting intermittent claudication and chronic limb-threatening ischemia as a covered benefit with conditions. ACR members who perform these procedures are encouraged to submit feedback. Email comments to shtap@hca.wa.gov.
Final findings and coverage decisions will be published in March. Meeting materials and presentations are on the HTCC website.
For more information or if you have questions, contact Alicia Blakey, ACR Principal Economic Policy Analyst.
MPFS Final Rule Decreases Conversion Factor for 2027
CMS finalized the 2027 Medicare Physician Fee Schedule, including conversion factor reductions and QPP policy updates.
Read moreCMS Finalizes Site-Neutral Payments for Non-Contrast Imaging Services in OPPS
ACR outlines key OPPS changes, including site-neutral payments for certain non-contrast imaging services beginning Jan. 1, 2027.
Read moreACR Applauds NRC for Adding IR to Medical Advisory Committee
ACR welcomes a new IR seat on the NRC advisory committee, strengthening expertise for radionuclide therapy, licensing and patient care.
Read more